News
KBC Group NV lifted its stake in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 6.1% in the 1st quarter, ...
1dOpinion
Zacks Investment Research on MSN4 Stocks to Watch in a Rapidly Shifting Outpatient Home Health SpaceThe Zacks Medical - Outpatient and Home Healthcare industry has been witnessing a rapid shift toward digital healthcare ...
A high-level overview of Bluejay Diagnostics, Inc. (BJDX) stock. View (BJDX) real-time stock price, chart, news, analysis, analyst reviews and more.
Of the 30 companies included in the list, 24 firms saw their stock prices rise, four saw their share prices decline, and two saw their stock prices remain flat.
Quest Diagnostics is expected to unveil its second-quarter results later this month, and analysts expect a single-digit ...
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks ...
BofA analysts review the promise and limits of AI in precision medicine, highlighting key players like Tempus, Guardant, and ...
While Quest Diagnostics has outshined the broader Nasdaq Composite over the past year, Wall Street analysts remain cautiously ...
Detailed price information for Thermo Fisher Scientific Inc (TMO-N) from The Globe and Mail including charting and trades.
Shares of Quest Diagnostics Inc. DGX slipped 1.71% to $178.95 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.84% to ...
GRAIL, Inc. was spun off from Illumina in 2024 and offers a promising multi-cancer early detection test called Galleri. Click here to read why GRAL is a Hold.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results